A medication that acts across several of those pathways could eventually become valuable in a broader clinical context
Importantly, when patients stop semaglutide, the weight they regain tends to be mostly fat mass not lean mass, leaving them potentially worse off in terms of joint support and musculoskeletal health
According to Monelle Burrus, a family nurse practitioner and health expert at Verve Health, Wegovy reduces the speed at which stomach contents are moved through the digestive system, a change that leads to constipation in the form of harder stools or infrequent bowel movements
Variants in genes like MC4R and FTO are linked to increased appetite for energy-dense foods, meaning some people are biologically predisposed to seek out sweets more intensely than others
Potential Interactions Between Creatine and Wegovy There is no documented pharmacological interaction between creatine and semaglutide at the molecular level
Date: November 16, 2025 Source: Cochrane Summary: GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility
